Program
formoterol
Also written as “Formoterol Fumarate”, “budesonide/formoterol” and “Formoterol”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Bronchitis, Chronic · Asthma, Exercise-Induced, led by 18 companies.
Drug pageFormoterol: every studyMany companies study it; this page follows only the 137 they lead. All 190 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AstraZenecaits history only | 632 open or running | phase 4since Jan 4, 2006 | Sep 13, 2005 | May 31, 2027phase 4 · NCT07073950 |
| Chiesi Farmaceuticiits history only | 200 open or running | phase 4since Nov 29, 2010 | Oct 30, 2006 | none ahead |
| Viatris | 160 open or running | phase 4since Nov 29, 2011 | Sep 13, 2005 | none ahead |
| Novartisits history only | 60 open or running | phase 4since Jul 26, 2005 | Jul 26, 2005 | none ahead |
| Sumitomo Pharmaits history only | 60 open or running | phase 4since Jan 17, 2007 | Jul 8, 2003 | none ahead |
| SkyePharmaits history only | 50 open or running | phase 3since Oct 27, 2006 | Oct 27, 2006 | none ahead |
| Eurofarma Laboratoriosits history only | 30 open or running | phase 3since Oct 23, 2009 | Oct 23, 2009 | none ahead |
| Mundipharmaits history only | 30 open or running | phase 4since Jun 15, 2015 | Oct 14, 2009 | none ahead |
| Ache Laboratorios Farmaceuticosits history only | 20 open or running | phase 3since Mar 9, 2011 | Mar 9, 2011 | none ahead |
| Boehringer Ingelheimits history only | 20 open or running | phase 2since Sep 11, 2014 | Sep 11, 2014 | none ahead |
| Intech Biopharmits history only | 20 open or running | phase 1since Jul 25, 2016 | Jul 25, 2016 | none ahead |
| Orion Corporation, Orion Pharmaits history only | 20 open or running | phase 2since Aug 24, 2009 | Aug 24, 2009 | none ahead |
| Zambon SpAits history only | 20 open or running | phase 1since Sep 2, 2014 | Sep 2, 2014 | none ahead |
| Chenpon Pharmaceuticalits history only | 10 open or running | phase 3since Aug 24, 2026 | Aug 24, 2026 | none ahead |
| Kindeva Drug Deliveryits history only | 10 open or running | phase 3since Jan 6, 2017 | Jan 6, 2017 | none ahead |
| Merckits history only | 10 open or running | phase 4since Aug 30, 2005 | Aug 30, 2005 | none ahead |
| Neutec Ar-Ge San ve Tic A.Şits history only | 10 open or running | phase 4since Oct 6, 2016 | Oct 6, 2016 | none ahead |
| Teva Pharmaceutical Industriesits history only | 10 open or running | phase 3since Jul 1, 2015 | Jul 1, 2015 | none ahead |
Also a collaborator on its studies: Parexel, CISCRP, eResearchTechnology, Menarini Group, Integrated Therapeutics Group and Pacira BioSciences.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Viatris only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 13, 2005First studies: 2 phase 3 studies in Pulmonary Disease, Chronic ObstructiveFirst studyNCT00215449, NCT00215436
- Sep 13, 20056 phase 2 studiesNCT00215423, NCT00215410, NCT00215397 and 3 more
- Jan 19, 2006Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT00280371 · 345 enrolled · United States
- Mar 27, 2006Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT00308191 · 128 enrolled · United States
- Nov 21, 2006Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT00403286 · 457 enrolled · United States
- Jul 24, 2007Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT00507234 · 128 enrolled · United States
- Oct 16, 2008Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT00774761 · 97 enrolled · United States
- Apr 27, 2010Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT01113593 · 45 enrolled · United States
- Jul 21, 2010Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT01168310 · 468 enrolled · United States
- Nov 29, 2011Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT01488019 · 1,071 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 16 Viatris leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01488019Pulmonary Disease, Chronic Obstructive · United States | 4 | Completed | Jan 2016 | 1,071 |
| NCT01168310Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Aug 2010 | 468 |
| NCT01113593Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | May 2010 | 45 |
| NCT00774761Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Apr 2009 | 97 |
| NCT00507234Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Oct 2007 | 128 |
| NCT00403286Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | May 2007 | 457 |
| NCT00308191Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | May 2006 | 128 |
| NCT00280371Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Jul 2006 | 345 |
| NCT00215449Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Dec 2005 | 690 |
| NCT00215436Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Sep 2005 | 345 |
| NCT00215423Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Dec 2003 | 49 |
| NCT00215410Asthma · United States | 2 | Completed | Oct 2003 | 36 |
| NCT00215397Asthma · United States | 2 | Completed | Feb 2003 | 16 |
| NCT00215384Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Apr 2003 | 35 |
| NCT00215371Asthma · United States | 2 | Completed | Oct 2002 | 32 |
| NCT00215358Asthma · United States | 2 | Completed | Oct 2002 | 32 |
How it is read
Names in the registry
- “Formoterol Fumarate”, 14 entries
- “budesonide/formoterol”, 10 entries
- “Formoterol”, 9 entries
- “Fluticasone Propionate/Formoterol Fumarate”, 9 entries
- “BGF MDI 320/14.4/9.6 μg”, 6 entries
Conditions, from the studies’ own filings
- Asthma, 75 studies
- Pulmonary Disease, Chronic Obstructive, 71 studies
- Bronchitis, Chronic, 2 studies
- Asthma, Exercise-Induced, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.